News . Data . Research
UnitedHealth Group Incorporated (NYSE: UNH) Q1 2023 earnings call dated Apr. 14, 2023 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk McMahon -- President and
UnitedHealth Group (NYSE: UNH) reported first quarter 2023 earnings results today. Revenues grew 15% year-over-year to $92 billion, helped by double-digit growth
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing their discoveries,
Shares of UnitedHealth Group Inc. (NYSE: UNH) stayed green on Wednesday. The stock has gained nearly 6% over the past three months.
Organigram Holdings, Inc. (NASDAQ: OGI) Q2 2023 earnings call dated Apr. 12, 2023 Corporate Participants: Max Schwartz -- Director of Investor Relations Beena Goldenberg -- Chief
Trxade Health Inc. (NASDAQ: MEDS), a leading online drug procurement marketplace, is on a mission to provide independent pharmacies a platform to
Abbott Laboratories (NYSE: ABT) has contributed significantly to COVID care activities by providing test kits, and the healthcare conglomerate’s revenues benefitted from
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) announced its commitment to developing viable treatment options for Hermansky-Pudlak Syndrome (HPS) on Thursday. The
Retail pharmacy chain CVS Health Corporation (NYSE: CVS) has been diversifying with the aim of tapping into emerging opportunities, while also aligning
Bio Path Holdings Inc (NASDAQ: BPTH) Q4 2022 earnings call dated Mar. 31, 2023 Corporate Participants: Will O'Connor -- Investor Relations Peter Nielsen -- Chief Executive
Walgreens Boots Alliance Inc (NASDAQ:WBA) Q2 2023 Earnings Call dated Mar. 28, 2023. Corporate Participants: Tiffany Kanaga -- Vice President, Global Investor Relations Rosalind
Neogen Corporation (NASDAQ: NEOG) Q3 2023 earnings call dated Mar. 30, 2023 Corporate Participants: Bill Waelke -- Vice President, Investor Relations John Adent -- Chief Executive
AngioDynamics Inc. (NASDAQ: ANGO) Q3 2023 earnings call dated Mar. 30, 2023 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported a wider loss for the third quarter when the medical device maker's revenues increased by
TC BioPharm (NASDAQ: TCBP) is a clinical-stage cell therapy company focused on the development of treatments for infectious diseases, including advanced allogeneic
TRxADE HEALTH Inc (NASDAQ:MEDS) Q4 2022 Earnings Call dated Mar. 27, 2023. Corporate Participants: Prashant Patel -- Chief Financial Officer Surendra Ajjarapu -- Founder, Chairman and
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported second quarter 2023 earnings results today. Sales increased 3.3% year-over-year to $34.9 billion. Net earnings
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a double-digit increase in revenues for fiscal 2022. The company's
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in retail pharmacy, has regularly revised its business model to better align with
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and commercializing their
RVL Pharmaceuticals plc (NASDAQ: RVLP) Q4 2022 earnings call dated Mar. 20, 2023 Corporate Participants: Lisa Wilson -- Investor Relations Brian Markison -- Chief Executive Officer